Welcome to CDC Stacks | Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis among HIV-infected Patients taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - 7283 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis among HIV-infected Patients taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
Filetype[PDF - 240.66 KB]


  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: